Abstract: An HPLC method for the determination of isovitexin in rat plasma and different tissues was developed. The separation was achieved on a C 18 column with a mobile phase consisting of methanol-1% acetum (40:60, v/v) at a detection wavelength of 338 nm and a column temperature of 30 °C. Rutin was chosen as the internal standard. The linear range of the standard curves was 0.20-128.75 μg/mL in the plasma and 0.024-3.09 μg/mL in the tissues. The LOQ was 0.19 μg/mL in the plasma and 0.024 μg/mL in the tissues. The relative recoveries of isovitexin ranged from 93% to 105% in the plasma and 87% to 112% in the tissues. The intra and inter day precisions were all below 8%. The pharmacokinetics and tissue distribution of isovitexin in rats were studied with the method. Blood samples were collected at fixed time intervals after the i.v. injection of isovitexin at a dosage of 18.75, 3.75 and 0.75 mg/kg; the tissue samples (brain, liver, kidney, heart, lung, spleen and ovary) were obtained at 10, 30, and 60 min after the i.v. injection of isovitexin at a dosage of 18.75 mg/kg. The pharmacokinetics of the isovitexin in three different dosages in the rats fit the twocompartment open model. The isovitexin displayed linear dynamics in the dosage range of 0.75-18.75 mg/kg. The mean value of t 1/2α was 1.54-1.84 min, and t 1/2β was 36.94-46.27 min at the three dosages. The tissue distribution study showed that the sequence of tissue drug concentration from high to low was kidney > liver > lung ≈ ovary > heart ≈ spleen > brain.
Introduction
Isovitexin, a Cglycosylflavone, exists in the leaves, flowers and fruits of many plants such as Cajanus cajan (Linn.) Millsp., Trollius chinensis Bunge. and Ficus microcarpa L.. It exhibits many biological activities including a remarkable antioxidation effect [1, 2] , strong antihyperglycemic action [3] , potential insulin secretagogue effects [4] and an anti inflammatory effect [5] . Most of these biological activities have been studied only by means of cells, and need to be confirmed by further investigation in animal bodies. But there is no analytical method for the determination of isovitexin in biological samples.
To support the pharmacokinetic and pharmacody namic study of isovitexin, an effective and sensitive method to determine its concentration in plasma is needed. An HPLC method has been established for vitexin (the isomer of isovitexin) detection in plasma and different tissues of the rat and dog [6, 7] . Because the solubility of isovitexin in water is much higher than that of vitexin, the two compounds might have different metabolism behavior in vivo. The aim of this research was to establish a reliable and accurate method for isovitexin detection in biological samples and study its pharmacokinetics and tissue distribution in rats.
Materials and methods

Materials and reagents
Isovitexin was extracted and purified from the leaves of Santalum album L., for the first time. The structure of the isovitexin ( Fig. 1 ) was elucidated by analyzing the spectral data (IR, MS, 1 H and 13 C NMR) and by comparison with the literature [8, 9] . The purity of the isovitexin for injection was over 98% by HPLC analysis. The methanol was of HPLC grade and obtained from Tedia (Tedia, USA). The ultrapure water was prepared by a MilliQ gradient water purification system (Millipore, Bedford, MA, USA). All other chemicals used in this study were of highpurity for analysis.
Animals
Male and female Sprague-Dawley rats weighing from 280 g to 350 g were brought from the Animal Center of Guangzhou University of Traditional Chinese Medicine. At least 1 week before the experi ments, they were housed in a temperaturecontrolled room ((22±2) °C) and were given free access to standard laboratory chow and tap water. All protocols and procedures were approved by our Institutional Animal Care and Use Committee.
HPLC conditions
The high performance liquid chromatography (HPLC) analysis system was Agilent 1200 (Agilent, USA) with a photodiode array detector (G1315 97004). The HPLC column was a TC C 18 column (250 mm×4.6 mm, 5 μm, Agilent, USA) connected with a guard column (EasyGuardC 18 Kit, 8 mm× 4 mm, Dikma). The separation was carried out with the mobile phase consisting of methanol-1% acetum (40:60, v/v) at a flow rate of 1.0 mL/min. The effluent was monitored at a wavelength of 338 nm and the temperature of the column was kept at 30 °C. The sample injection volume was 20 μL.
Preparation of samples for HPLC analysis
First, 100 μL of the plasma sample for the pharmacokinetic study or 400 μL of the pretreated tissue sample (ovarian tissue was 200 μL) for the tissue distribution study were mixed with 50 μL of 0.2 mg/mL rutin (internal standard) and 500 μL methanol. Then they were thoroughly vortexmixed for 1 min before being centrifuged at 12 000×g (4 °C) for 12 min. The supernatant was collected into another microcentrifuge tube and kept at 40 °C under nitrogen gas flow for drying. The residues were dissolved in mobile phase and centrifuged at 12 000×g for 5 min again. Finally, 20 μL of the resulting solution was injected into the HPLC system for pharmacokinetic or tissue distribution studies.
Method validation
The method validation was conducted according to the Guiding Principle of NonClinical Pharma cokinetics Research of Chemical Drugs (serial number [H] GPT51, China) for specificity, linearity, precision, limit of detection, accuracy and extracted recovery. A series of standard solutions with concen trations ranging from 1.94 μg/mL to 495.00 μg/mL were prepared by dilution of the stock solution (495 μg/mL) with methanol. Standard solutions (10-50 μL) and internal standard solutions (0.2 mg/mL methanol, 50 μL) were added to 100 μL blank rat plasma or 400 μL blank tissue homogenate. The mixture was then treated according to sample extraction procedures.
Specificity
Blank samples and spiked blank samples of blood and tissues from six rats were prepared and used for the specificity study.
Calibration curve and limit of quantitation (LOQ)
The calibration curves were constructed using linear regression analysis based on the ratio of the peak area of the isovitexin to the internal standard. LOQ was defined as the lowest concentration at which both precision and accuracy were not more than 20%.
Accuracy and precision
The accuracy and precision were investigated by determining the QC samples of isovitexin at three concentration levels. Precision was expressed as relative standard deviation (RSD) and accuracy as relative error (RE). 
Stability and extraction recoveries
For the recovery study, plasma and liver homoge nate were spiked with isovitexin at concentrations of 0.39, 3.09 and 24.75 μg/mL, and then treated according to the above sample extraction proce dures. The recovery was determined as the ratio of the peak area of the QC samples to that of the reference samples prepared in methanol at the same concentrations.
The stability of the isovitexin in the biosamples was investigated under a variety of storage condi tions and processing procedures. For the storage stability study, the samples (five replicates at each QC concentration) were prepared and stored at −20 °C for 7 d. For the freezethaw stability study, the QC samples were determined after three freeze thaw cycles. For the room temperature stability study, the QC samples were kept at room temperature ((29±2) °C) for 24 h. Thus all the samples were determined and compared with freshly prepared samples.
Pharmacokinetic experiments
A vascular cannula was implanted at least 1 d before the experiments in the rats. On the experi ment day, the rats were anesthetized using chloral hydrate (3% concentration, 1 mL/100 g). The right femoral artery was exposed and a heparinzed (diluted with saline to 31 IU/mL) venous indwelling needle (24 G, 20 mm Shanghai Puyi Medical Instruments Co., Ltd. China) was inserted for blood sampling. After surgery, the rats received an intravenous bolus injection of a mixture of sulfadiazine and trimethoprime diluted with saline (50 and 10 mg/kg, respectively). The antibiotic mixture was also applied to the wounds. The cannulas were flushed with heparinized saline (31 IU/mL) every day.
Isovitexin solutions at concentrations of 11.25, 2.25 and 0.45 mg/mL were prepared by dissolution of isovitexin in propylene glycol-redistilled water (1:9, v/v) followed by filtering through a 0.22 μm filter before the experiment. Eighteen rats were randomly assigned to three groups. Each group contained six rats (the male/female ratio was 50:50). Isovitexin solution was administered to the rats via a tail vein injection at a dose of 18.75, 3.75, 0.75 mg/kg. At 2, 5, 10, 15, 20, 30, 45, 60, 90 and 120 min after the drug injection, 0.3 mL blood samples were drawn into a heparinized syringe via the femoral artery cannula each time. Then the blood samples were put into heparinized microcentrifuge tubes followed by centrifuging at 12 000×g at a tem perature of 4 °C for 10 min. Finally, 100 μL plasma layers were separated and stored in microcentrifuge tubes at 4 °C for HPLC analysis within 2 d.
Tissue distribution experiments
On the test day, eighteen female rats were ran domly assigned to three groups. Each group con tained six rats. Each rat received isovitexin solution via a tail vein injection at a dose of 18.75 mg/kg. At 10, 30, or 60 min after the injection, the rats were lightly sedated with carbon dioxide and decapitated. In our preliminary tests, this light exposure to carbon dioxide did not affect the isovitexin concentrations in the tissues. Immediately after the decapitation, trunk blood was collected in a heparinized tube. Brain, liver, kidney, heart, lung, spleen, and ovary samples were obtained and immersed in saline solu tion quickly to remove the blood, then homogenized in saline solution (400 mg/mL), and stored at a con stant temperature of 4 °C before using within 2 d.
Results and discussion
Animal experiment
We chose the femoral artery, which can supply enough blood immediately, and which is also difficult to be blocked by thrombus. In order to avoid a thrombus blockade, the cannula was flushed with heparinized saline every day.
Chromatography
In the present study, vitexin, naringin, orientin and rutin were selected to study their chromatographic behavior. Rutin was chosen as the internal standard because it had the appropriate retention time and enough stability. Sharp and symmetric peaks and a stable retention time were obtained when the mobile phase was 1% acetum-methanol (60:40, v/v, pH = 4.3). According to the maximum absorption spectrum of isovitexin (the maximum absorption spectrum for rutin is 355 nm), 338 nm was chosen as a detection wavelength to guarantee enough detecting sensitivity.
Sample preparation
Protein precipitating agents and their dosage were investigated in this experiment. At first, acetonitrile was selected for its excellent effect on protein pre cipitation. However, the result showed that the peak area of the rutin treated by the acetonitrile was much smaller than that treated by the same concentration of methanol solution. A solubility test confirmed that rutin had very low solubility in acetonitrile. So methanol was used as a protein precipitating agent with high recovery. The dosage of the protein pre cipitating agent was also studied. For plasma, at least 5 times volume of methanol could make the test sample solution clear. However, the tissue test sample will be muddier with the increasing amount of protein precipitating agent because more of the lipophilic component has been extracted, which will not be dissolved by the mobile phase. So the tissue test samples were purified through centrifugation before injecting to HPLC.
Method validation
Specificity
Isovitexin has been well separated and no inter ferences were detected from endogenous substances or metabolites. The representative chromatogram of isovitexin is showed in Figures 2 and 3 , the reten tion time for isovitexin and internal standard was approximately 12 and 13.5 min, respectively.
Calibration curve and limit of quantitation
The standard curves, correlation coefficients and linear ranges of the isovitexin in the plasma and all Table 1 . The LOQ of the isovitexin was 0.19 μg/mL in the plasma and 0.024 μg/mL in the tissues (n = 6).
Accuracy and precision
The results showed that the relative recoveries of isovitexin ranged from 93% to 105% in the plasma and 87% to 112% in the tissues. The RSD of the intraday precision and the interday precision were both less than 8%.
Stability and extraction recoveries
The mean recoveries of isovitexin in the plasma at three different concentrations (0.39, 3.09 and 24.75 μg/mL) were 68.2%, 74.4% and 78.7% , respectively, and the RSD were 10.6%, 7.5% and 6.1%, respectively, at the three concentration levels.
The samples in a variety of storage conditions and processing procedures were almost identical to those of freshly prepared QC samples (RSD<8.0%), indicating good stability of this method.
Pharmacokinetic and statistical analyses
The data from the pharmacokinetic study were analyzed using modelindependent methods and compartmental analysis by DAS 2.1.1 version. The goodness of fit and the most appropriate model were determined by assessing the randomness of the scatter of the actual data points around the fitted function and according to the AIC (Akaike, 1976).
The concentrationtime curves of the isovitexin in the plasma samples for the three groups of rats with various doses of intravenous administration are shown in Figure 4 . The pharmacokinetic parameters calculated from the data are summarized in Table 2 .
The results showed that the pharmacokinetics of the The pharmacokinetic of isovitexin after oral administration was also studied. When the dosage was up to 40 mg/kg, the concentration of isovitexin in the plasma was still very low. So the oral administra tion of isovitexin was of little practical significance. and 2 times higher than in the heart and spleen.
The blood flow or perfusion rate of the ovary is obviously lower than that of the abovementioned organs. Thus it is suggested that isovitexin has strong affinity with the ovary. High distribution of isovitexin in the kidney, liver and lung will give us instruction in the investigation of curative effects on the respiratory and urinary system and on liver diseases.
Conclusion
A simple RPHPLC method with rutin as the 
